470 related articles for article (PubMed ID: 21281743)
1. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
[TBL] [Abstract][Full Text] [Related]
2. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.
Soltész P; Dér H; Kerekes G; Szodoray P; Szücs G; Dankó K; Shoenfeld Y; Szegedi G; Szekanecz Z
Clin Rheumatol; 2009 Jun; 28(6):655-62. PubMed ID: 19224126
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in rheumatic autoimmune diseases.
Murdaca G; Colombo BM; Cagnati P; Gulli R; Spanò F; Puppo F
Atherosclerosis; 2012 Oct; 224(2):309-17. PubMed ID: 22673743
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do.
Szekanecz Z; Kerekes G; Végh E; Kardos Z; Baráth Z; Tamási L; Shoenfeld Y
Autoimmun Rev; 2016 Jul; 15(7):756-69. PubMed ID: 26979271
[TBL] [Abstract][Full Text] [Related]
7. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
8. Cardiac manifestations in antiphospholipid syndrome.
Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
[TBL] [Abstract][Full Text] [Related]
9. Macrovascular disease and atherosclerosis in SSc.
Hettema ME; Bootsma H; Kallenberg CG
Rheumatology (Oxford); 2008 May; 47(5):578-83. PubMed ID: 18321944
[TBL] [Abstract][Full Text] [Related]
10. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
11. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
Jara LJ; Medina G; Vera-Lastra O; Amigo MC
Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
[TBL] [Abstract][Full Text] [Related]
12. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
[TBL] [Abstract][Full Text] [Related]
13. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary hypertension in autoimmune rheumatic diseases].
Marasini B; Massarotti M; Cossutta R; Massironi L; Mantero A
Reumatismo; 2005; 57(2):114-8. PubMed ID: 15983635
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of disease: atherosclerosis in autoimmune diseases.
Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2006 Feb; 2(2):99-106. PubMed ID: 16932663
[TBL] [Abstract][Full Text] [Related]
16. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
17. Rheumatic diseases and Klinefelter's syndrome.
Rovenský J; Imrich R; Lazúrová I; Payer J
Ann N Y Acad Sci; 2010 Apr; 1193():1-9. PubMed ID: 20398000
[TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune-mediated atherothrombosis.
Matsuura E; Lopez LR
Lupus; 2008 Oct; 17(10):878-87. PubMed ID: 18827052
[TBL] [Abstract][Full Text] [Related]
20. Malignancies in autoimmune rheumatic diseases - a mini-review.
Szekanecz Z; Szekanecz E; Bakó G; Shoenfeld Y
Gerontology; 2011; 57(1):3-10. PubMed ID: 20453490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]